1 Great Valley Parkway; Suite 30
Malvern,  PA  19355

United States
  • Booth: 2218

PhaseBio introduces REVERSE-IT [] (Rapid and SustainEd ReVERSal of TicagrElor - Intervention Trial), a pivotal Phase 3 tiral designed to study the reversal of the antiplatelet effects of ticagrelor with bentracimab in patients who present with uncontrolled major or life-threatening bleeding or who require surgery or an invasive procedure. For more information, please visit PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases. PhaseBio is located in Malvern, PA and San Diego, CA.